Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Core EBITDA Margin

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Margin(%) 7.698.358.2615.9616.07

What is the latest Core EBITDA Margin ratio of GLENMARK PHARMACEUTICALS ?

The latest Core EBITDA Margin ratio of GLENMARK PHARMACEUTICALS is 7.69 based on Mar2023 Consolidated results.
Year Core EBITDA Margin
Mar20237.69
Mar20228.35
Mar20218.26
Mar202015.96
Mar201916.07

How is Core EBITDA Margin of GLENMARK PHARMACEUTICALS Trending?

Years Core EBITDA Margin % Change
Mar2023 7.69
-7.90
Mar2022 8.35
1.09
Mar2021 8.26
-48.25
Mar2020 15.96
-0.68
Mar2019 16.07 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Core EBITDA Margin ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹29,927.3 Cr -1.8% 10.8% 91.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹364,315.0 Cr -0.1% -6.3% 53.5% Stock Analytics
CIPLA ₹114,614.0 Cr 1% -5% 53.3% Stock Analytics
DIVIS LABORATORIES ₹105,233.0 Cr 3.2% 15.3% 23.6% Stock Analytics
DR REDDYS LABORATORIES ₹104,900.0 Cr 1.1% 2.2% 26% Stock Analytics
ZYDUS LIFESCIENCES ₹99,426.0 Cr 3.9% -1.7% 85.2% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.8%

10.8%

91.6%

SENSEX

1%

2.2%

23.7%


You may also like the below Video Courses